• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Protalix BioTherapeutics, Inc. (DE) Common Stock (NY:PLX)

2.640 -0.090 (-3.30%)
Official Closing Price Updated: 4:10 PM EDT, Sep 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 644,641
Open 2.740
Bid (Size) 2.650 (400)
Ask (Size) 2.660 (100)
Prev. Close 2.730
Today's Range 2.615 - 2.750
52wk Range 1.600 - 3.190
Shares Outstanding 73,633,583
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Protalix (PLX) Q2 2026 Earnings Call Transcript ↗
August 19, 2026
Elfabrio sales surge drives $19.9M quarterly revenue and $22.1M H1 net income. 
Via The Motley Fool
Topics Earnings Intellectual Property
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 18, 2026
Via Chartmill

Performance

YTD
+51.7%
+51.7%
1 Month
+8.6%
+8.6%
3 Month
+28.8%
+28.8%
6 Month
-5.4%
-5.4%
1 Year
+56.2%
+56.2%

More News

Read More
Discover the top movers in Wednesday's pre-market session. ↗
March 18, 2026
Via Chartmill
PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy ↗
January 30, 2026
Via Stocktwits
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Via Benzinga
Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors? ↗
October 17, 2025
Via Stocktwits
News headline image
Earnings Scheduled For August 14, 2025 ↗
August 14, 2025
Via Benzinga
News headline image
Preview: Protalix BioTherapeutics's Earnings ↗
August 13, 2025
Via Benzinga
News headline image
Preview: Protalix BioTherapeutics's Earnings ↗
November 12, 2025
Via Benzinga
News headline image
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
November 05, 2025
From Schall Law
Via GlobeNewswire
News headline image
PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm
October 31, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Top stock movements in today's session. ↗
October 17, 2025
Via Chartmill
News headline image
Why Is Protalix BioTherapeutics Stock Falling On Friday? ↗
October 17, 2025
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
October 17, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 17, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 02, 2025
Via Benzinga
News headline image
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
September 16, 2025
Via ACCESS Newswire
News headline image
Protalix BioTherapeutics to Present at Investor Summit Virtual
September 11, 2025
Via ACCESS Newswire
News headline image
Protalix Revenue Jumps 16 Percent in Q2 ↗
August 14, 2025
Via The Motley Fool
News headline image
Top movers in Friday's session ↗
May 09, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
May 09, 2025
Via Chartmill
News headline image
The market is filled with gapping stocks in Friday's session. ↗
May 09, 2025
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
May 09, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
May 09, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2025 ↗
May 09, 2025
Via Benzinga

Frequently Asked Questions

Is Protalix BioTherapeutics, Inc. (DE) Common Stock publicly traded?
Yes, Protalix BioTherapeutics, Inc. (DE) Common Stock is publicly traded.
What exchange does Protalix BioTherapeutics, Inc. (DE) Common Stock trade on?
Protalix BioTherapeutics, Inc. (DE) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock?
The ticker symbol for Protalix BioTherapeutics, Inc. (DE) Common Stock is PLX on the New York Stock Exchange
What is the current price of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The current price of Protalix BioTherapeutics, Inc. (DE) Common Stock is 2.640
When was Protalix BioTherapeutics, Inc. (DE) Common Stock last traded?
The last trade of Protalix BioTherapeutics, Inc. (DE) Common Stock was at 09/11/26 04:10 PM ET
What is the market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock?
The market capitalization of Protalix BioTherapeutics, Inc. (DE) Common Stock is 194.39M
How many shares of Protalix BioTherapeutics, Inc. (DE) Common Stock are outstanding?
Protalix BioTherapeutics, Inc. (DE) Common Stock has 194M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap